Mayflower Financial Advisors LLC Boosts Stock Position in Stryker Corporation (NYSE:SYK)

Mayflower Financial Advisors LLC raised its position in shares of Stryker Corporation (NYSE:SYK - Free Report) by 44.5% during the 1st quarter, according to the company in its most recent 13F filing with the SEC. The fund owned 4,414 shares of the medical technology company's stock after purchasing an additional 1,359 shares during the quarter. Mayflower Financial Advisors LLC's holdings in Stryker were worth $1,643,000 at the end of the most recent reporting period.

Other large investors have also added to or reduced their stakes in the company. Capital A Wealth Management LLC purchased a new stake in shares of Stryker in the fourth quarter worth about $26,000. Goodman Advisory Group LLC purchased a new stake in shares of Stryker in the first quarter worth about $32,000. City Holding Co. boosted its stake in shares of Stryker by 528.6% in the first quarter. City Holding Co. now owns 88 shares of the medical technology company's stock worth $33,000 after buying an additional 74 shares during the last quarter. VSM Wealth Advisory LLC purchased a new stake in shares of Stryker in the fourth quarter worth about $36,000. Finally, Smallwood Wealth Investment Management LLC purchased a new stake in shares of Stryker in the first quarter worth about $40,000. Hedge funds and other institutional investors own 77.09% of the company's stock.

Insider Activity at Stryker

In related news, Director Ronda E. Stryker sold 200,000 shares of the stock in a transaction that occurred on Tuesday, May 6th. The stock was sold at an average price of $376.96, for a total value of $75,392,000.00. Following the completion of the sale, the director owned 3,417,326 shares of the company's stock, valued at approximately $1,288,195,208.96. This trade represents a 5.53% decrease in their ownership of the stock. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which can be accessed through this link. Corporate insiders own 5.90% of the company's stock.

Stryker Price Performance

Shares of Stryker stock opened at $390.65 on Thursday. The business has a 50 day simple moving average of $385.38 and a two-hundred day simple moving average of $377.55. Stryker Corporation has a 12 month low of $314.93 and a 12 month high of $406.19. The stock has a market capitalization of $149.11 billion, a P/E ratio of 52.79, a PEG ratio of 2.95 and a beta of 0.91. The company has a debt-to-equity ratio of 0.69, a current ratio of 1.64 and a quick ratio of 1.00.

Stryker (NYSE:SYK - Get Free Report) last posted its quarterly earnings results on Thursday, May 1st. The medical technology company reported $2.84 EPS for the quarter, beating the consensus estimate of $2.73 by $0.11. Stryker had a return on equity of 23.74% and a net margin of 12.31%. The firm had revenue of $5.87 billion during the quarter, compared to analysts' expectations of $5.68 billion. During the same quarter last year, the firm earned $2.50 earnings per share. The business's revenue for the quarter was up 11.9% on a year-over-year basis. As a group, analysts predict that Stryker Corporation will post 13.47 EPS for the current fiscal year.

Stryker Announces Dividend

The business also recently declared a quarterly dividend, which will be paid on Thursday, July 31st. Investors of record on Monday, June 30th will be issued a $0.84 dividend. The ex-dividend date of this dividend is Monday, June 30th. This represents a $3.36 annualized dividend and a dividend yield of 0.86%. Stryker's dividend payout ratio is presently 45.41%.

Analyst Upgrades and Downgrades

A number of equities analysts recently weighed in on SYK shares. Evercore ISI upped their price target on Stryker from $390.00 to $415.00 and gave the stock an "outperform" rating in a report on Tuesday, July 8th. Citigroup reaffirmed a "buy" rating and issued a $455.00 price target (up previously from $443.00) on shares of Stryker in a report on Thursday, May 22nd. Wall Street Zen cut Stryker from a "buy" rating to a "hold" rating in a report on Friday, June 27th. Roth Mkm upped their price target on Stryker from $405.00 to $456.00 and gave the stock a "buy" rating in a report on Friday, May 2nd. Finally, Sanford C. Bernstein set a $450.00 price target on Stryker in a report on Monday, May 5th. Five research analysts have rated the stock with a hold rating and fifteen have given a buy rating to the stock. Based on data from MarketBeat, the company has a consensus rating of "Moderate Buy" and a consensus target price of $428.55.

Stryker Profile

Stryker Corporation operates as a medical technology company. The company operates through two segments, MedSurg and Neurotechnology, and Orthopaedics and Spine. The Orthopaedics and Spine segment provides implants for use in total joint replacements, such as hip, knee and shoulder, and trauma and extremities surgeries.

Want to see what other hedge funds are holding SYK? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Stryker Corporation (NYSE:SYK - Free Report).

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.